Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications." title="" class="btn" data-container="body" data-html="true" data-id="252862" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#0077b5" tabindex="0" data-original-title="Ancilia Biosciences"> 3,100
Activities
Technologies
Entity types
Employees
Scale: 2-10
Estimated: 15
Engaged corporates
1Added in Motherbase
2 months, 3 weeks agoAncilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Deep Science Ventures Startup accelerator & VC, Venture Capital and Private Equity Principals | Deep Science Ventures Startup accelerator & VC, Venture Capital and Private Equity Principals | Other 19 Jul 2024 | |